Market Share of Global Orphan Drugs Industry
The orphan drugs market is moderately competitive. In terms of market share, a few of the major players currently dominate the market. With the rising number of diseases and an increasing number of cases each year, a few smaller players are entering the market and holding a substantial share. Some of the market players include Celgene Corporation, Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, F. Hoffmann-La Roche Ltd and others.
Orphan Drugs Market Leaders
-
Takeda Pharmaceutical Company Limited
-
Novartis AG
-
Johnson & Johnson
-
F. Hoffmann-La Roche Ltd
-
Bristol-Myers Squibb Company (Celgene Corporation)
*Disclaimer: Major Players sorted in no particular order
